'Sinovac Vaccine Probably Won't Arrive Next Month'

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1566925_1_20201224181337.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1566925-20201224.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1566925-20201224.htm', 'DCS.dcsqry', '' ); } } }); }); });

2020-12-24 HKT 11:42

Share this story

facebook

  • David Hui says the Sinovac vaccine probably won't reach Hong Kong next month as expected. File photo: RTHK

    David Hui says the Sinovac vaccine probably won't reach Hong Kong next month as expected. File photo: RTHK

A government adviser on the pandemic said on Thursday that there will likely be a month's delay for Sinovac's vaccine to reach Hong Kong, as reports said the release of the jab's latest trial results in Brazil is being pushed back.

The mainland vaccine manufacturer was originally expected to publish its vaccine's phase three efficacy data around Wednesday, but it has now asked for the release to be put back by up to 15 days so that it can analyse the data from Brazil alongside that collected in Indonesia and Turkey.

Brazilian researchers said on Wednesday that preliminary data suggests Sinovac jabs are "more than 50 percent effective".

Health Secretary Sophia Chan had previously expected Hong Kong to get hold of the vaccine in January and have people injected by February or March.

But Chinese University's Professor David Hui said on a radio programme that the jabs will probably arrive only in February, adding that the BioNTech/Fosun Pharma vaccine may be the first available in the city.

Meanwhile, University of Hong Kong microbiologist Ho Pak-leung played down concerns over Sinovac’s delay in announcing the latest clinical data.

“For mainland vaccines, relevant departments like the National Medical Products Administration have tight supervision over the production and other areas,” he told an RTHK programme.

He added that the technology used by Sinovac to make the vaccine is mature.

But he urged the government to keep pushing for more information on the vaccine's efficacy on mutated coronavirus strains. (Additional reporting by Reuters)

RECENT NEWS

ZA Bank Brings Nasdaq Data To Hong Kong, Expanding US Stock Access And Investor Education

ZA Bank and Nasdaq have announced a collaboration aimed at enhancing digital wealth management in Hong Kong and interna... Read more

Hong Kong To Study One‑Stop Infrastructure For Equities, Bonds And Digital Assets

The Hong Kong Monetary Authority’s (HKMA) CMU OmniClear and the Hong Kong Exchange (HKEX) are set to begin a study on... Read more

Hong Kong To Issue First Stablecoin Licenses In March, Expand Crypto Regulation

Hong Kong will issue its first licenses for fiat-referenced stablecoin issuers in March and introduce new legislation l... Read more

MSIG Joins US$6B IFC Credit Insurance Facility To Boost Emerging Market Lending

MSIG USA and Mitsui Sumitomo Insurance (MSI Japan), together referred to as MSIG, have joined a new insurance-ba... Read more

Why The $2 Trillion Stablecoin Prediction Is Too Low

McKinsey estimates the stablecoin market will hit $2 trillion by 2028. But according to Sam Lin, COO of dtcpay, even th... Read more

RedotPay Eyes US IPO With Potential US$1 Billion Raise

RedotPay is reportedly exploring an IPO in the US that could raise more than US$1 billion, according to people famili... Read more